Chlorbutol, naphazoline, phenylephrine
Sold as Nazo-ezze, Nitro nose
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 2
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharma-q Holdings (Pty) LtdCancelled | Nazo-ezze | Not stated | H1452 | Not determined | None |
| Shanur Healthcare (Pty) Ltd | Nitro nose | drops | H1464 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Nazo-ezze EACH 10,0 ml SOLUTION CONTAINS CHLORBUTOL A 0,05 g NAPHAZOLINE NITRATE A 0,0025 g PHENYLEPHRINE HYDROCHLORIDE A 0,025 g | Not listed | H1452 | Cancelled | Not determined | None |
| Nitro nose drops EACH 20 ml CONTAINS CHLORBUTOL A 0,05 g NAPHAZOLINE NITRATE A 0,0025 g PHENYLEPHRINE HYDROCHLORIDE A 0,025 g | Drops | H1464 | Old Medicine | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.